3,4-methylenedioxyamphetamine has been researched along with Apraxia in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Excerpt | Relevance | Reference |
---|---|---|
"A survey was sent to members of the Dyspraxia Support Group of New Zealand asking participants to prioritise the three factors that had most positively and negatively influenced the development of the young person's SE." | 1.56 | Coordination difficulties and self-esteem: The views of children, adolescents, and their parents. ( Eggleston, M; Frampton, C; Hanger, N; Watkins, W, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Eggleston, M | 1 |
Watkins, W | 1 |
Frampton, C | 1 |
Hanger, N | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Apraxia
Article | Year |
---|---|
Coordination difficulties and self-esteem: The views of children, adolescents, and their parents.
Topics: Adolescent; Apraxias; Child; Family Relations; Female; Humans; Love; Male; Motor Skills Disorders; N | 2020 |